Table 1 General characteristics of the included 9 guidelines
Guidelines identifier, Yeara | Organization(s) responsible for guidelines development | Target population | Proportion of authors RWI | AGREE II score, % | Number of Echo recommendations | Guideline status |
|---|---|---|---|---|---|---|
AHA, 2015 | American Heart Association | Adult IE | 4/16 (25.0%) | 77 | 5 | Strongly recommended |
ESC, 2015 | European Society of Cardiology | IE | 13/20 (65.0%) | 75 | 10 | Strongly recommended |
BSAC, 2011 | British Society for Antimicrobial Chemotherapy | Adult IE | 2/9 (22.2%) | 54 | 7 | Recommended |
BSAC/BHRS, 2014 | British Society for Antimicrobial Chemotherapy, British Heart Rhythm Society | Infections related to ICED | 4/12 (33.3%) | 62 | 5 | Strongly recommended |
SEIMC, 2015 | Spanish Society of Infectious Diseases and Clinical Microbiology | IE caused by S.aureus | 6/17 (35.3%) | 53 | 5 | Recommended |
SSID, 2007 | Swedish Society of Infectious Diseases | IE | – | 36 | 6 | Recommended |
CSC, 2015 | Chinese Society of Cardiology | Adult IE | – | 39 | 9 | Recommended |
JCS, 2017 | Japanese Circulation Society | IE | 7/24 (29.2%) | 55 | 10 | Recommended |
NHAM, 2017 | National Heart Association of Malaysia | IE | 0/13 (0%) | 79 | 7 | Strongly recommended |